About
Addiction Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (59)
View allTotal Trials
59
As Lead Sponsor
51
As Collaborator
8
Total Enrollment
10,256
By Phase
PHASE2: 12PHASE1: 13PHASE4: 11PHASE3: 8NA: 3
By Status
COMPLETED: 49TERMINATED: 3RECRUITING: 2ACTIVE_NOT_RECRUITING: 2UNKNOWN: 2WITHDRAWN: 1
Clinical Trials Pipeline59 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07174869Lead Sponsor
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
N/ARecruiting
55 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2026
NCT06576843Lead Sponsor
INDV-6001 Multiple-Dose Pharmacokinetic Study
PHASE2Active, not recruiting
122 participants
Started: Sep 17, 2024 · Completed: Dec 31, 2025
NCT06384157Lead Sponsor
Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder
PHASE2Active, not recruiting
300 participants
Started: Jun 10, 2024 · Completed: Dec 31, 2025
NCT05878210Lead Sponsor
Evaluating the SUBLOCADE Treatment Exit Strategy
N/ACompleted
12 participants
Started: Nov 24, 2023 · Completed: May 9, 2025
NCT05860959Lead Sponsor
SUBLOCADE Long-term Outcomes
N/ACompleted
480 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2025
Locations (1)
Headquarters
Slough, UK
Map
Loading map...